Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-015857
Filing Date
2025-02-07
Accepted
2025-02-07 07:30:57
Documents
117
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K itrm-20241231.htm   iXBRL 10-K 5248427
2 EX-4.20 itrm-ex4_20.htm EX-4.20 209353
3 EX-10.22 itrm-ex10_22.htm EX-10.22 596979
4 EX-23.1 itrm-ex23_1.htm EX-23.1 4190
5 EX-31.1 itrm-ex31_1.htm EX-31.1 17575
6 EX-31.2 itrm-ex31_2.htm EX-31.2 17599
7 EX-32.1 itrm-ex32_1.htm EX-32.1 9949
8 EX-32.2 itrm-ex32_2.htm EX-32.2 9942
9 GRAPHIC img248307334_0.jpg GRAPHIC 89708
10 GRAPHIC img248307334_1.jpg GRAPHIC 1095038
11 GRAPHIC img248307334_2.jpg GRAPHIC 151682
12 GRAPHIC img248307334_3.jpg GRAPHIC 93590
13 GRAPHIC img248307334_4.jpg GRAPHIC 182598
14 GRAPHIC img248307334_5.jpg GRAPHIC 135330
  Complete submission text file 0000950170-25-015857.txt   23483336

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20241231.xsd EX-101.SCH 2143687
120 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20241231_htm.xml XML 3422486
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38503 | Film No.: 25599305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)